Peter Kirkpatrick
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
Papers in
- Oncology 29
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 7
- Co-authors
- Uma Yasothan (16 shared papers)Mohamed Muhsin (5 shared papers)Clare Ellis (1 shared paper)Guy Bate (7 shared papers)Argyris Dritselis (8 shared papers)Seden Grippon (4 shared papers)C.A. Jones (4 shared papers)John D. Minna (2 shared papers)
- Journals
- Nature Reviews Drug Discovery (137 papers)Chemical Communications (3 papers)Nature reviews. Cancer (2 papers)Nature (1 paper)Australian Literary Studies (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter Kirkpatrick
143 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 168
- Oncology 1.3k
- Pharmacology 664
- Molecular Biology 2.8k
- Organic Chemistry 1.1k
- Applied Microbiology and Biotechnology 62
Countries citing papers authored by Peter Kirkpatrick
This map shows the geographic impact of Peter Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kirkpatrick more than expected).
Fields of papers citing papers by Peter Kirkpatrick
This network shows the impact of papers produced by Peter Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kirkpatrick. The network helps show where Peter Kirkpatrick may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kirkpatrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 264 | |
| 2 | 1998 | 260 | |
| 3 | 2004 | 215 | |
| 4 | 2005 | 186 | |
| 5 | 2012 | 168 | |
| 6 | 2010 | 157 | |
| 7 | 2006 | 152 | |
| 8 | 2010 | 149 | |
| 9 | 2012 | 146 | |
| 10 | 2007 | 135 | |
| 11 | 2011 | 128 | |
| 12 | 2010 | 127 | |
| 13 | 2006 | 124 | |
| 14 | 2011 | 124 | |
| 15 | 2003 | 124 | |
| 16 | 2004 | 124 | |
| 17 | 2005 | 121 | |
| 18 | 2011 | 115 | |
| 19 | 2006 | 115 | |
| 20 | 2012 | 107 |
About Peter Kirkpatrick
Peter Kirkpatrick is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases and Pharmacology, having authored 150 papers that have together received 6.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), HIV/AIDS drug development and treatment (10 papers), Cancer Treatment and Pharmacology (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), HER2/EGFR in Cancer Research (7 papers), Computational Drug Discovery Methods (7 papers), HIV Research and Treatment (6 papers) and Microbial Natural Products and Biosynthesis (6 papers). The work is most often cited by research in Oncology (1.3k citations), Pharmacology (664 citations), Molecular Biology (2.8k citations), Organic Chemistry (1.1k citations) and Applied Microbiology and Biotechnology (62 citations). Peter Kirkpatrick has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Uma Yasothan, Mohamed Muhsin, Clare Ellis, Guy Bate, Argyris Dritselis, Seden Grippon, C.A. Jones, John D. Minna, Jonathan E. Dowell and Hagop M. Kantarjian. Their work appears in journals such as Nature Reviews Drug Discovery, Chemical Communications, Nature reviews. Cancer, Nature and Australian Literary Studies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.